Selexipag;2-[4-[(5,6-Diphenylpyrazin-2-yl)-propan-2-ylamino]butoxy]-N-methylsulfonylacetamide

Details:

Seasons Biotechnology (Taizhou) Co., Ltd. is an R&D driven pharmaceutical enterprise, focusing on the research and development of innovative drugs, providing patients with high-quality cardiovascular, depression drugs and chronic disease management services 

Established in 2012, seasons is a national high-tech enterprise. It masters dozens of domestic and foreign invention patents. Many API and formulation products have been approved by US FDA. The quality system and lab have been audited by FDA. Products are promoted to Europe, USA, Japan and emerging markets.

The company has a professional research team and long-term collaborations with top international universities (Lanzhou University, Nankai University, Zhejiang University, Nagoya University，Washington State University) and State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources. Seasons R&D laboratory has advanced pharmaceutical chemistry, pharmacology, formulation instruments and equipment.

The analysis laboratory is located near taizhou high-speed railway station, Zhejiang Province, with LCMS, GCMS, and XRPD equipment, which can cary out a wide range of testing and characteristics analysis, in line with cGMP standards, to undertake entrusted inspection and release. 

We also have a number of sales with rich experience in international trade, who can provide good customer experiences. In order to ensure the quality of products, a comprehensive testing and analysis will be provided to our customers. We will provide our customers with first-class products and services by strengthening internal management and expanding the business market.